FOXO4-DRIvsPentadeca Arginate
FOXO4-DRI vs Pentadeca Arginate — independent comparison of uses, administration, pricing across providers, and key differences. Last reviewed April 21, 2026.
Quick Verdict
Based on clinical evidence and real patient data
A D-amino acid retro-inverso peptide designed to disrupt the interaction between FOXO4 and p53 in senescent cells, triggering apoptosis of these 'zombie cells.' A first-in-class senolytic peptide with potential to clear senescent cell burden.
A stable arginate salt form of a 15-amino-acid sequence related to BPC-157. Developed as a compounding-pharmacy-compatible alternative following FDA regulatory pressure on BPC-157. Offers similar regenerative and anti-inflammatory benefits through overlapping pathways.
Best choice depends on your insurance, budget, and treatment history.Take the quiz to get a personalized recommendation.
FOXO4-DRI vs Pentadeca Arginate: At a Glance
Full comparison across all key factors.
| Factor | FOXO4-DRI | Pentadeca ArginateALLY PICK |
|---|---|---|
| Category | anti-aging | recovery |
| Also Known As | Senostatin, FOXO4-p53 DRI peptide | PDA, BPC-157 arginate |
| Administration | Subcutaneous injection | Subcutaneous injection or oral capsule |
| Prescription | Required | Required |
| Providers | 2 providers | 5 providers✓ Better |
| Common Uses |
|
|
Data sourced from FDA prescribing information and peer-reviewed clinical trials. Prices reflect telehealth platform costs as of April 21, 2026. See our methodology.
Pricing by Provider
2 providers offer both FOXO4-DRI and Pentadeca Arginate.
| Provider | FOXO4-DRI | Pentadeca Arginate | Consultation | Lab Testing |
|---|---|---|---|---|
 | $450/per-cycle | $175/monthly | Video Telehealth | Yes |
 | $550/per-cycle | $230/monthly | Video Telehealth | Yes |
 | Not offered | $190/monthly | Video Telehealth | Yes |
 | Not offered | $160/monthly | Video Telehealth | No |
 | Not offered | $189/monthly | Async Telehealth | Yes |
Key Differences
FOXO4-DRI
A D-amino acid retro-inverso peptide designed to disrupt the interaction between FOXO4 and p53 in senescent cells, triggering apoptosis of these 'zombie cells.' A first-in-class senolytic peptide with potential to clear senescent cell burden.
Pentadeca Arginate
More ProvidersA stable arginate salt form of a 15-amino-acid sequence related to BPC-157. Developed as a compounding-pharmacy-compatible alternative following FDA regulatory pressure on BPC-157. Offers similar regenerative and anti-inflammatory benefits through overlapping pathways.
Which Is Right for You?
Choose FOXO4-DRIif…
- You want a anti-aging medication
- You prefer subcutaneous injection administration
- 2 providers available on our platform
- Your primary goal is senescent cell clearance
- Your primary goal is tissue rejuvenation
Choose Pentadeca Arginateif…
- You want a recovery medication
- You prefer subcutaneous injection or oral capsule administration
- You want more provider options (5 available)
- Your primary goal is tendon and ligament repair
- Your primary goal is gut healing
Frequently Asked Questions
What is the difference between FOXO4-DRI and Pentadeca Arginate?
Which is cheaper, FOXO4-DRI or Pentadeca Arginate?
Can I switch from FOXO4-DRI to Pentadeca Arginate?
Medical Disclaimer
This comparison is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting, stopping, or changing any medication. Individual results may vary. The information presented reflects publicly available data and may not account for your specific health situation.